2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 27601593 | Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. | 2017 Mar 1 | 1 |
| 2 | 25708834 | Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes. | 2015 Jul | 1 |